Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD

Swapnil Hiremath¹, Michaeline McGuinty², Christos Argyropoulos³, K Scott Brimble^{4

5}, Pierre Antoine Brown¹, Zain Chagla⁴, Rebecca Cooper^{5

6}, Stephanie Hoar¹, David Juurlink⁷, Darin Treleaven^{4

6}, Michael Walsh^{8

9

10}, Angie Yeung⁵, Peter Blake^{5

11}

Affiliations

¹ Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada.
² Division of Infectious Disease, Department of Medicine, University of Ottawa, Ottawa, Canada.
³ Division of Nephrology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.
⁴ Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Canada.
⁵ Ontario Renal Network, Ontario Health, Toronto, Canada.
⁶ Trillium Gift of Life Network, Ontario Health, Toronto, Ontario.
⁷ Department of Medicine, Sunnybrook Hospital and University Health Network, Toronto, Canada.
⁸ Department of Medicine, McMaster University, Hamilton, Canada.
⁹ Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada.
¹⁰ Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Canada.
¹¹ Division of Nephrology, Department of Medicine, Western University, London, Canada.

Swapnil Hiremath et al. Clin J Am Soc Nephrol. 2022 Aug.

. 2022 Aug;17(8):1247-1250.

doi: 10.2215/CJN.05270522. Epub 2022 Jun 9.

¹ Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada.
² Division of Infectious Disease, Department of Medicine, University of Ottawa, Ottawa, Canada.
³ Division of Nephrology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.
⁴ Division of Nephrology, Department of Medicine, McMaster University, Hamilton, Canada.
⁵ Ontario Renal Network, Ontario Health, Toronto, Canada.
⁶ Trillium Gift of Life Network, Ontario Health, Toronto, Ontario.
⁷ Department of Medicine, Sunnybrook Hospital and University Health Network, Toronto, Canada.
⁸ Department of Medicine, McMaster University, Hamilton, Canada.
⁹ Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada.
¹⁰ Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Canada.
¹¹ Division of Nephrology, Department of Medicine, Western University, London, Canada.

No abstract available

Keywords: COVID-19; chronic kidney disease; dialysis; drug metabolism; pharmacokinetics; transplantation.

Figures

1. Collaborators C-EM; COVID-19 Excess Mortality Collaborators : Estimating excess mortality due to the COVID-19 pandemic: A systematic analysis of COVID-19-related mortality, 2020-21. Lancet 399: 1513–1536, 2022 - PMC - PubMed
1. Pakhchanian H, Raiker R, Mukherjee A, Khan A, Singh S, Chatterjee A: Outcomes of COVID-19 in CKD patients: A multicenter electronic medical record cohort study. Clin J Am Soc Nephrol 16: 785–786, 2021 - PMC - PubMed
1. Taji L, Thomas D, Oliver MJ, Ip J, Tang Y, Yeung A, Cooper R, House AA, McFarlane P, Blake PG: COVID-19 in patients undergoing long-term dialysis in Ontario. CMAJ 193: E278–E284, 2021 - PMC - PubMed
1. Carr EJ, Kronbichler A, Graham-Brown M, Abra G, Argyropoulos C, Harper L, Lerma EV, Suri RS, Topf J, Willicombe M, Hiremath S: Review of early immune response to SARS-CoV-2 vaccination among patients with CKD. Kidney Int Rep 6: 2292–2304, 2021 - PMC - PubMed
1. Prendecki M, Thomson T, Clarke CL, Martin P, Gleeson S, De Aguiar RC, Edwards H, Mortimer P, McIntyre S, Mokreri D, Cox A, Pickard G, Lightstone L, Thomas D, McAdoo SP, Kelleher P, Willicombe M; Imperial Renal COVID-19 vaccine study group in collaboration with the OCTAVE Study Consortium : Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients. Lancet 398: 1482–1484, 2021 - PMC - PubMed